The long-term survival of patients with III-IVb stage nasopharyngeal carcinoma treated with IMRT with or without Nimotuzumab: a propensity score-matched analysis.

Wang Zhi-QiangMei QiLi Ji-BinYou RuiLiu You-PingSun RuiHu Guang-YuanChen Ming-YuanJin-Hua Chen

Published in: BMC cancer (2019)

This nimotuzumab-containing regimen resulted in improved long-term survival of III-IVb stage NPC patients and warrants further prospective evaluation.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
patient reported outcomes